Silver Book Fact

Development of a neuroprotective drug could potentially reduce disability from stroke by 50%.

Goldman D, Shang B, Bhattacharya J, Garber A, et al. Consequences of Health Trends and Medical Innovation for the Future Elderly: Health and costs of the future elderly. Health Affairs Web Exclusive Collection. 2005; 24(2). https://www.healthaffairs.org/doi/full/10.1377/hlthaff.W5.R5

Reference

Title
Consequences of Health Trends and Medical Innovation for the Future Elderly: Health and costs of the future elderly
Publication
Health Affairs Web Exclusive Collection
Publication Date
2005
Authors
Goldman D, Shang B, Bhattacharya J, Garber A, et al.
Volume & Issue
Volume 24, Issue 2
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Medicines in Development for Heart Disease and Stroke, 2008  
  • Anti-platelet therapy stroke risk reduction
    Anti-platelet therapy after a stroke or TIA reduces the risk of nonfatal ischemic strokes by 28% and fatal strokes by 16%.  
  • Savings associated with t-PA treatment for ischemic stroke patients
    A $600 net savings is associated with each ischemic stroke patient treated with t-PA. In 2005, only 2% of all ischemic stroke patients received t-PA. If that percentage was increased…  
  • The volume of mitral valve surgical procedures increased approximately 8.3% from 2010 to 2013.
     
  • An estimated 70% of survival improvement in heart attack mortality is attributed to technological advances and procedures developed over the past 30 years, including CABG (coronary artery bypass graft), PTCA…